Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact
Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: PIAS1

Gene summary for PIAS1

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

PIAS1

Gene ID

8554

Gene nameprotein inhibitor of activated STAT 1
Gene AliasDDXBP1
Cytomap15q23
Gene Typeprotein-coding
GO ID

GO:0000003

UniProtAcc

O75925


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
8554PIAS1CCI_2HumanCervixCC1.38e-111.35e+000.5249
8554PIAS1CCI_3HumanCervixCC2.25e-057.26e-010.516
8554PIAS1L1HumanCervixCC1.18e-02-1.57e-010.0802
8554PIAS1HTA11_3410_2000001011HumanColorectumAD2.64e-14-4.77e-010.0155
8554PIAS1HTA11_3361_2000001011HumanColorectumAD1.99e-02-4.74e-01-0.1207
8554PIAS1HTA11_866_2000001011HumanColorectumAD9.34e-04-3.32e-01-0.1001
8554PIAS1HTA11_866_3004761011HumanColorectumAD4.48e-08-4.58e-010.096
8554PIAS1HTA11_7663_2000001011HumanColorectumSER7.74e-03-2.90e-010.0131
8554PIAS1HTA11_10711_2000001011HumanColorectumAD3.18e-05-4.74e-010.0338
8554PIAS1HTA11_7696_3000711011HumanColorectumAD1.66e-10-4.67e-010.0674
8554PIAS1HTA11_99999970781_79442HumanColorectumMSS1.08e-07-3.99e-010.294
8554PIAS1HTA11_99999971662_82457HumanColorectumMSS1.21e-09-5.12e-010.3859
8554PIAS1HTA11_99999973899_84307HumanColorectumMSS4.64e-02-4.93e-010.2585
8554PIAS1HTA11_99999974143_84620HumanColorectumMSS2.23e-06-4.61e-010.3005
8554PIAS1A001-C-207HumanColorectumFAP1.69e-03-2.40e-010.1278
8554PIAS1A015-C-203HumanColorectumFAP1.79e-27-3.88e-01-0.1294
8554PIAS1A015-C-204HumanColorectumFAP2.01e-07-3.47e-01-0.0228
8554PIAS1A014-C-040HumanColorectumFAP2.19e-04-3.51e-01-0.1184
8554PIAS1A002-C-201HumanColorectumFAP8.24e-17-3.59e-010.0324
8554PIAS1A002-C-203HumanColorectumFAP4.10e-04-1.96e-010.2786
Page: 1 2 3 4 5 6 7 8 9 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
CervixThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.CC: Cervix cancer
HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions
N_HPV: HPV-infected normal cervix
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
LungThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AAH: Atypical adenomatous hyperplasia
AIS: Adenocarcinoma in situ
IAC: Invasive lung adenocarcinoma
MIA: Minimally invasive adenocarcinoma
Oral CavityThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.EOLP: Erosive Oral lichen planus
LP: leukoplakia
NEOLP: Non-erosive oral lichen planus
OSCC: Oral squamous cell carcinoma
ProstateThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.BPH: Benign Prostatic Hyperplasia
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:004316131Oral cavityNEOLPproteasome-mediated ubiquitin-dependent protein catabolic process89/2005412/187236.27e-117.44e-0989
GO:004573233Oral cavityNEOLPpositive regulation of protein catabolic process58/2005231/187233.80e-103.18e-0858
GO:200005834Oral cavityNEOLPregulation of ubiquitin-dependent protein catabolic process46/2005164/187235.31e-104.20e-0846
GO:004586233Oral cavityNEOLPpositive regulation of proteolysis80/2005372/187237.28e-105.54e-0880
GO:190305034Oral cavityNEOLPregulation of proteolysis involved in cellular protein catabolic process54/2005221/187234.32e-092.49e-0754
GO:003243433Oral cavityNEOLPregulation of proteasomal ubiquitin-dependent protein catabolic process38/2005134/187231.19e-085.70e-0738
GO:190336433Oral cavityNEOLPpositive regulation of cellular protein catabolic process41/2005155/187232.87e-081.22e-0641
GO:006113632Oral cavityNEOLPregulation of proteasomal protein catabolic process46/2005187/187234.76e-081.95e-0646
GO:004544422Oral cavityNEOLPfat cell differentiation50/2005229/187236.79e-071.93e-0550
GO:003243632Oral cavityNEOLPpositive regulation of proteasomal ubiquitin-dependent protein catabolic process26/200590/187231.58e-063.89e-0526
GO:200006032Oral cavityNEOLPpositive regulation of ubiquitin-dependent protein catabolic process29/2005107/187231.72e-064.19e-0529
GO:004269221Oral cavityNEOLPmuscle cell differentiation71/2005384/187232.97e-066.76e-0571
GO:190180031Oral cavityNEOLPpositive regulation of proteasomal protein catabolic process29/2005114/187236.80e-061.36e-0429
GO:190305232Oral cavityNEOLPpositive regulation of proteolysis involved in cellular protein catabolic process32/2005133/187238.26e-061.60e-0432
GO:190332231Oral cavityNEOLPpositive regulation of protein modification by small protein conjugation or removal31/2005138/187234.77e-056.58e-0431
GO:001820531Oral cavityNEOLPpeptidyl-lysine modification64/2005376/187231.21e-041.43e-0364
GO:000008231Oral cavityNEOLPG1/S transition of mitotic cell cycle40/2005214/187233.21e-043.11e-0340
GO:004477231Oral cavityNEOLPmitotic cell cycle phase transition67/2005424/187237.30e-045.98e-0367
GO:000931432Oral cavityNEOLPresponse to radiation71/2005456/187237.84e-046.25e-0371
GO:004484331Oral cavityNEOLPcell cycle G1/S phase transition41/2005241/187231.87e-031.28e-0241
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
hsa0412014CervixCCUbiquitin mediated proteolysis49/1267142/84654.26e-097.68e-084.54e-0849
hsa0412015CervixCCUbiquitin mediated proteolysis49/1267142/84654.26e-097.68e-084.54e-0849
hsa04120ColorectumADUbiquitin mediated proteolysis58/2092142/84651.46e-051.53e-049.76e-0558
hsa05160ColorectumADHepatitis C54/2092157/84653.87e-031.96e-021.25e-0254
hsa041201ColorectumADUbiquitin mediated proteolysis58/2092142/84651.46e-051.53e-049.76e-0558
hsa051601ColorectumADHepatitis C54/2092157/84653.87e-031.96e-021.25e-0254
hsa041202ColorectumSERUbiquitin mediated proteolysis39/1580142/84656.18e-033.66e-022.66e-0239
hsa041203ColorectumSERUbiquitin mediated proteolysis39/1580142/84656.18e-033.66e-022.66e-0239
hsa041204ColorectumMSSUbiquitin mediated proteolysis55/1875142/84655.02e-066.00e-053.68e-0555
hsa051602ColorectumMSSHepatitis C52/1875157/84659.29e-045.58e-033.42e-0352
hsa041205ColorectumMSSUbiquitin mediated proteolysis55/1875142/84655.02e-066.00e-053.68e-0555
hsa051603ColorectumMSSHepatitis C52/1875157/84659.29e-045.58e-033.42e-0352
hsa041206ColorectumFAPUbiquitin mediated proteolysis51/1404142/84651.55e-085.84e-073.55e-0751
hsa041207ColorectumFAPUbiquitin mediated proteolysis51/1404142/84651.55e-085.84e-073.55e-0751
hsa041208ColorectumCRCUbiquitin mediated proteolysis42/1091142/84659.98e-086.67e-064.52e-0642
hsa041209ColorectumCRCUbiquitin mediated proteolysis42/1091142/84659.98e-086.67e-064.52e-0642
hsa0412026EsophagusHGINUbiquitin mediated proteolysis49/1383142/84657.78e-081.33e-061.06e-0649
hsa04120111EsophagusHGINUbiquitin mediated proteolysis49/1383142/84657.78e-081.33e-061.06e-0649
hsa0412027EsophagusESCCUbiquitin mediated proteolysis122/4205142/84656.53e-207.29e-183.74e-18122
hsa051609EsophagusESCCHepatitis C107/4205157/84651.75e-061.08e-055.55e-06107
Page: 1 2 3 4 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
PIAS1SNVMissense_Mutationnovelc.946N>Cp.Glu316Glnp.E316QO75925protein_codingdeleterious(0.01)probably_damaging(0.917)TCGA-B6-A40B-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
PIAS1SNVMissense_Mutationc.1063C>Tp.His355Tyrp.H355YO75925protein_codingdeleterious(0)probably_damaging(1)TCGA-C8-A26Y-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
PIAS1SNVMissense_Mutationnovelc.97C>Ap.His33Asnp.H33NO75925protein_codingtolerated(0.07)benign(0.031)TCGA-OL-A6VR-01Breastbreast invasive carcinomaFemale<65I/IIUnknownUnknownSD
PIAS1insertionFrame_Shift_Insnovelc.1948_1949insATGCTCCCACACATCCTCAp.Ile650AsnfsTer43p.I650Nfs*43O75925protein_codingTCGA-A2-A0EO-01Breastbreast invasive carcinomaFemale<65I/IIHormone TherapytamoxiphenSD
PIAS1insertionFrame_Shift_Insnovelc.1729_1730insATTTTTTTATCTTTTATACCATATTp.Leu577HisfsTer25p.L577Hfs*25O75925protein_codingTCGA-AO-A0JD-01Breastbreast invasive carcinomaFemale<65III/IVChemotherapycyclophosphamideSD
PIAS1SNVMissense_Mutationnovelc.985N>Cp.Thr329Prop.T329PO75925protein_codingdeleterious(0)probably_damaging(0.995)TCGA-2W-A8YY-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
PIAS1SNVMissense_Mutationnovelc.569N>Gp.Ser190Cysp.S190CO75925protein_codingdeleterious(0.01)probably_damaging(0.962)TCGA-C5-A7X5-01Cervixcervical & endocervical cancerFemale>=65I/IIChemotherapycarboplatinPD
PIAS1SNVMissense_Mutationc.1250C>Tp.Pro417Leup.P417LO75925protein_codingdeleterious(0)possibly_damaging(0.701)TCGA-A6-2686-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
PIAS1SNVMissense_Mutationc.1372N>Gp.Lys458Glup.K458EO75925protein_codingdeleterious(0)benign(0.18)TCGA-A6-4105-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownPD
PIAS1SNVMissense_Mutationc.85N>Ap.Gly29Argp.G29RO75925protein_codingdeleterious(0)probably_damaging(0.999)TCGA-AA-3947-01Colorectumcolon adenocarcinomaFemale<65I/IIUnknownUnknownSD
Page: 1 2 3 4 5 6 7 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1